Atlas Trials

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

Clinical trial NCT02093546 · COMPLETED

Trial details

NCT number
NCT02093546
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Recurrent Endometrial Carcinoma
Start date
2004-08-13
Primary completion
2020-01-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.